People · Operator
Named in public records as an officer, director or promoter · active 2017–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| BELLUS Health Inc. | — | Biotechnology | Series B | $33.6M | $951.4M | 2017 |
Tony Matzouranis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tony Matzouranis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Francois Desjardins | 1 | 1 |
| Franklin L. Berger | 1 | 1 |
| Clarissa L. Desjardins | 1 | 1 |
| Roberto Bellini | 1 | 1 |
| Joseph L. Rus | 1 | 1 |
| Pierre L. Larochelle | 1 | 1 |
| Chau Quang Khuong | 1 | 1 |
| Youssef L. Bennani | 1 | 1 |
| Francesco Bellini | 1 | 1 |
| Denis Garceau | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.